List of Tables
Table 1. mRNA Vaccines & Therapeutics Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Infectious Disease Vaccines
Table 3. Major Players of Cancer Vaccines
Table 4. Global mRNA Vaccines & Therapeutics Sales by Type (2016-2021) & (M Doses)
Table 5. Global mRNA Vaccines & Therapeutics Sales Market Share by Type (2016-2021)
Table 6. Global mRNA Vaccines & Therapeutics Revenue by Type (2016-2021) & ($ million)
Table 7. Global mRNA Vaccines & Therapeutics Revenue Market Share by Type (2016-2021)
Table 8. Global mRNA Vaccines & Therapeutics Sale Price by Type (2016-2021)
Table 9. Global mRNA Vaccines & Therapeutics Sales by Application (2016-2021) & (M Doses)
Table 10. Global mRNA Vaccines & Therapeutics Sales Market Share by Application (2016-2021)
Table 11. Global mRNA Vaccines & Therapeutics Value by Application (2016-2021)
Table 12. Global mRNA Vaccines & Therapeutics Revenue Market Share by Application (2016-2021)
Table 13. Global mRNA Vaccines & Therapeutics Sale Price by Application (2016-2021)
Table 14. Global mRNA Vaccines & Therapeutics Sales by Company (2019-2021) & (M Doses)
Table 15. Global mRNA Vaccines & Therapeutics Sales Market Share by Company (2019-2021)
Table 16. Global mRNA Vaccines & Therapeutics Revenue by Company (2019-2021) ($ Millions)
Table 17. Global mRNA Vaccines & Therapeutics Revenue Market Share by Company (2019-2021)
Table 18. Global mRNA Vaccines & Therapeutics Sale Price by Company (2019-2021)
Table 19. Key Manufacturers mRNA Vaccines & Therapeutics Producing Area Distribution and Sales Area
Table 20. Players mRNA Vaccines & Therapeutics Products Offered
Table 21. mRNA Vaccines & Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 22. New Products and Potential Entrants
Table 23. Mergers & Acquisitions, Expansion
Table 24. Global mRNA Vaccines & Therapeutics Sales by Region (2016-2021) (M Doses)
Table 25. Global mRNA Vaccines & Therapeutics Sales Market Share by Region (2016-2021)
Table 26. Global mRNA Vaccines & Therapeutics Revenue by Region (2016-2021) & ($ Millions)
Table 27. Global mRNA Vaccines & Therapeutics Revenue Market Share by Region (2016-2021)
Table 28. Americas mRNA Vaccines & Therapeutics Sales by Country (2016-2021) & (M Doses)
Table 29. Americas mRNA Vaccines & Therapeutics Sales Market Share by Country (2016-2021)
Table 30. Americas mRNA Vaccines & Therapeutics Revenue by Country (2016-2021) & ($ Millions)
Table 31. Americas mRNA Vaccines & Therapeutics Revenue Market Share by Country (2016-2021)
Table 32. Americas mRNA Vaccines & Therapeutics Sales by Type (2016-2021) & (M Doses)
Table 33. Americas mRNA Vaccines & Therapeutics Sales Market Share by Type (2016-2021)
Table 34. Americas mRNA Vaccines & Therapeutics Sales by Application (2016-2021) & (M Doses)
Table 35. Americas mRNA Vaccines & Therapeutics Sales Market Share by Application (2016-2021)
Table 36. APAC mRNA Vaccines & Therapeutics Sales by Region (2016-2021) & (M Doses)
Table 37. APAC mRNA Vaccines & Therapeutics Sales Market Share by Region (2016-2021)
Table 38. APAC mRNA Vaccines & Therapeutics Revenue by Region (2016-2021) & ($ Millions)
Table 39. APAC mRNA Vaccines & Therapeutics Revenue Market Share by Region (2016-2021)
Table 40. APAC mRNA Vaccines & Therapeutics Sales by Type (2016-2021) & (M Doses)
Table 41. APAC mRNA Vaccines & Therapeutics Sales Market Share by Type (2016-2021)
Table 42. APAC mRNA Vaccines & Therapeutics Sales by Application (2016-2021) & (M Doses)
Table 43. APAC mRNA Vaccines & Therapeutics Sales Market Share by Application (2016-2021)
Table 44. Europe mRNA Vaccines & Therapeutics Sales by Country (2016-2021) & (M Doses)
Table 45. Europe mRNA Vaccines & Therapeutics Sales Market Share by Country (2016-2021)
Table 46. Europe mRNA Vaccines & Therapeutics Revenue by Country (2016-2021) & ($ Millions)
Table 47. Europe mRNA Vaccines & Therapeutics Revenue Market Share by Country (2016-2021)
Table 48. Europe mRNA Vaccines & Therapeutics Sales by Type (2016-2021) & (M Doses)
Table 49. Europe mRNA Vaccines & Therapeutics Sales Market Share by Type (2016-2021)
Table 50. Europe mRNA Vaccines & Therapeutics Sales by Application (2016-2021) & (M Doses)
Table 51. Europe mRNA Vaccines & Therapeutics Sales Market Share by Application (2016-2021)
Table 52. Middle East & Africa mRNA Vaccines & Therapeutics Sales by Country (2016-2021) & (M Doses)
Table 53. Middle East & Africa mRNA Vaccines & Therapeutics Sales Market Share by Country (2016-2021)
Table 54. Middle East & Africa mRNA Vaccines & Therapeutics Revenue by Country (2016-2021) & ($ Millions)
Table 55. Middle East & Africa mRNA Vaccines & Therapeutics Revenue Market Share by Country (2016-2021)
Table 56. Middle East & Africa mRNA Vaccines & Therapeutics Sales by Type (2016-2021) & (M Doses)
Table 57. Middle East & Africa mRNA Vaccines & Therapeutics Sales Market Share by Type (2016-2021)
Table 58. Middle East & Africa mRNA Vaccines & Therapeutics Sales by Application (2016-2021) & (M Doses)
Table 59. Middle East & Africa mRNA Vaccines & Therapeutics Sales Market Share by Application (2016-2021)
Table 60. Key and Potential Regions of mRNA Vaccines & Therapeutics
Table 61. Key Application and Potential Industries of mRNA Vaccines & Therapeutics
Table 62. Key Challenges of mRNA Vaccines & Therapeutics
Table 63. Key Trends of mRNA Vaccines & Therapeutics
Table 64. mRNA Vaccines & Therapeutics Distributors List
Table 65. mRNA Vaccines & Therapeutics Customer List
Table 66. Global mRNA Vaccines & Therapeutics Sales Forecast by Region (2021-2026) & (M Doses)
Table 67. Global mRNA Vaccines & Therapeutics Consumption Market Forecast by Region
Table 68. Global mRNA Vaccines & Therapeutics Revenue Forecast by Region (2021-2026) & ($ millions)
Table 69. Global mRNA Vaccines & Therapeutics Revenue Market Share Forecast by Region (2021-2026)
Table 70. Americas mRNA Vaccines & Therapeutics Sales Forecast by Country (2021-2026) & (M Doses)
Table 71. Americas mRNA Vaccines & Therapeutics Revenue Forecast by Country (2021-2026) & ($ millions)
Table 72. APAC mRNA Vaccines & Therapeutics Sales Forecast by Region (2021-2026) & (M Doses)
Table 73. APAC mRNA Vaccines & Therapeutics Revenue Forecast by Region (2021-2026) & ($ millions)
Table 74. Europe mRNA Vaccines & Therapeutics Sales Forecast by Country (2021-2026) & (M Doses)
Table 75. Europe mRNA Vaccines & Therapeutics Revenue Forecast by Country (2021-2026) & ($ millions)
Table 76. Middle East & Africa mRNA Vaccines & Therapeutics Sales Forecast by Country (2021-2026) & (M Doses)
Table 77. Middle East & Africa mRNA Vaccines & Therapeutics Revenue Forecast by Country (2021-2026) & ($ millions)
Table 78. Global mRNA Vaccines & Therapeutics Sales Forecast by Type (2021-2026) & (M Doses)
Table 79. Global mRNA Vaccines & Therapeutics Sales Market Share Forecast by Type (2021-2026)
Table 80. Global mRNA Vaccines & Therapeutics Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 81. Global mRNA Vaccines & Therapeutics Revenue Market Share Forecast by Type (2021-2026)
Table 82. Global mRNA Vaccines & Therapeutics Sales Forecast by Application (2021-2026) & (M Doses)
Table 83. Global mRNA Vaccines & Therapeutics Sales Market Share Forecast by Application (2021-2026)
Table 84. Global mRNA Vaccines & Therapeutics Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 85. Global mRNA Vaccines & Therapeutics Revenue Market Share Forecast by Application (2021-2026)
Table 86. Moderna Therapeutics Basic Information, mRNA Vaccines & Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 87. Moderna Therapeutics mRNA Vaccines & Therapeutics Product Offered
Table 88. Moderna Therapeutics mRNA Vaccines & Therapeutics Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2019-2021E)
Table 89. Moderna Therapeutics Main Business
Table 90. Moderna Therapeutics Latest Developments
Table 91. CureVac Basic Information, mRNA Vaccines & Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 92. CureVac mRNA Vaccines & Therapeutics Product Offered
Table 93. CureVac mRNA Vaccines & Therapeutics Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2019-2021E)
Table 94. CureVac Main Business
Table 95. CureVac Latest Developments
Table 96. Translate Bio Basic Information, mRNA Vaccines & Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 97. Translate Bio mRNA Vaccines & Therapeutics Product Offered
Table 98. Translate Bio mRNA Vaccines & Therapeutics Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2019-2021E)
Table 99. Translate Bio Main Business
Table 100. Translate Bio Latest Developments
Table 101. BioNTech Basic Information, mRNA Vaccines & Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 102. BioNTech mRNA Vaccines & Therapeutics Product Offered
Table 103. BioNTech mRNA Vaccines & Therapeutics Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2019-2021E)
Table 104. BioNTech Main Business
Table 105. BioNTech Latest Developments
Table 106. Sangamo Therapeutics Basic Information, mRNA Vaccines & Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 107. Sangamo Therapeutics mRNA Vaccines & Therapeutics Product Offered
Table 108. Sangamo Therapeutics mRNA Vaccines & Therapeutics Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2019-2021E)
Table 109. Sangamo Therapeutics Main Business
Table 110. Sangamo Therapeutics Latest Developments
Table 111. Argos Therapeutics Basic Information, mRNA Vaccines & Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 112. Argos Therapeutics mRNA Vaccines & Therapeutics Product Offered
Table 113. Argos Therapeutics mRNA Vaccines & Therapeutics Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2019-2021E)
Table 114. Argos Therapeutics Main Business
Table 115. Argos Therapeutics Latest Developments
Table 116. In-Cell-Art Basic Information, mRNA Vaccines & Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 117. In-Cell-Art mRNA Vaccines & Therapeutics Product Offered
Table 118. In-Cell-Art mRNA Vaccines & Therapeutics Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2019-2021E)
Table 119. In-Cell-Art Main Business
Table 120. In-Cell-Art Latest Developments
Table 121. eTheRNA Basic Information, mRNA Vaccines & Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 122. eTheRNA mRNA Vaccines & Therapeutics Product Offered
Table 123. eTheRNA mRNA Vaccines & Therapeutics Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2019-2021E)
Table 124. eTheRNA Main Business
Table 125. eTheRNA Latest Developments
Table 126. Ethris Basic Information, mRNA Vaccines & Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 127. Ethris mRNA Vaccines & Therapeutics Product Offered
Table 128. Ethris mRNA Vaccines & Therapeutics Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2019-2021E)
Table 129. Ethris Main Business
Table 130. Ethris Latest Developments
Table 131. Tiba Biotechnology Basic Information, mRNA Vaccines & Therapeutics Manufacturing Base, Sales Area and Its Competitors
Table 132. Tiba Biotechnology mRNA Vaccines & Therapeutics Product Offered
Table 133. Tiba Biotechnology mRNA Vaccines & Therapeutics Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2019-2021E)
Table 134. Tiba Biotechnology Main Business
Table 135. Tiba Biotechnology Latest Developments

LIST OF FIGURE

List of Figures
Figure 1. Picture of mRNA Vaccines & Therapeutics
Figure 2. mRNA Vaccines & Therapeutics Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global mRNA Vaccines & Therapeutics Sales Growth Rate 2016-2026 (M Doses)
Figure 7. Global mRNA Vaccines & Therapeutics Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. mRNA Vaccines & Therapeutics Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Infectious Disease Vaccines
Figure 10. Product Picture of Cancer Vaccines
Figure 11. Global mRNA Vaccines & Therapeutics Sales Market Share by Type in 2020
Figure 12. Global mRNA Vaccines & Therapeutics Revenue Market Share by Type (2016-2021)
Figure 13. mRNA Vaccines & Therapeutics Consumed in Infectious Disease
Figure 14. Global mRNA Vaccines & Therapeutics Market: Infectious Disease (2016-2021) & (M Doses)
Figure 15. mRNA Vaccines & Therapeutics Consumed in Cancer
Figure 16. Global mRNA Vaccines & Therapeutics Market: Cancer (2016-2021) & (M Doses)
Figure 17. Global mRNA Vaccines & Therapeutics Sales Market Share by Application (2016-2021)
Figure 18. Global mRNA Vaccines & Therapeutics Revenue Market Share by Application in 2020
Figure 19. mRNA Vaccines & Therapeutics Revenue Market by Company in 2020 ($ Million)
Figure 20. Global mRNA Vaccines & Therapeutics Revenue Market Share by Company in 2020
Figure 21. Global mRNA Vaccines & Therapeutics Sales Market Share by Regions (2016-2021)
Figure 22. Global mRNA Vaccines & Therapeutics Revenue Market Share by Region in 2020
Figure 23. Americas mRNA Vaccines & Therapeutics Sales 2016-2021 (M Doses)
Figure 24. Americas mRNA Vaccines & Therapeutics Revenue 2016-2021 ($ Millions)
Figure 25. APAC mRNA Vaccines & Therapeutics Sales 2016-2021 (M Doses)
Figure 26. APAC mRNA Vaccines & Therapeutics Revenue 2016-2021 ($ Millions)
Figure 27. Europe mRNA Vaccines & Therapeutics Sales 2016-2021 (M Doses)
Figure 28. Europe mRNA Vaccines & Therapeutics Revenue 2016-2021 ($ Millions)
Figure 29. Middle East & Africa mRNA Vaccines & Therapeutics Sales 2016-2021 (M Doses)
Figure 30. Middle East & Africa mRNA Vaccines & Therapeutics Revenue 2016-2021 ($ Millions)
Figure 31. Americas mRNA Vaccines & Therapeutics Sales Market Share by Country in 2020
Figure 32. Americas mRNA Vaccines & Therapeutics Revenue Market Share by Country in 2020
Figure 33. Americas mRNA Vaccines & Therapeutics Sales Market Share by Type in 2020
Figure 34. Americas mRNA Vaccines & Therapeutics Sales Market Share by Application in 2020
Figure 35. United States mRNA Vaccines & Therapeutics Revenue Growth 2016-2021 ($ Millions)
Figure 36. Canada mRNA Vaccines & Therapeutics Revenue Growth 2016-2021 ($ Millions)
Figure 37. Mexico mRNA Vaccines & Therapeutics Revenue Growth 2016-2021 ($ Millions)
Figure 38. Brazil mRNA Vaccines & Therapeutics Revenue Growth 2016-2021 ($ Millions)
Figure 39. APAC mRNA Vaccines & Therapeutics Sales Market Share by Region in 2020
Figure 40. APAC mRNA Vaccines & Therapeutics Revenue Market Share by Regions in 2020
Figure 41. APAC mRNA Vaccines & Therapeutics Sales Market Share by Type in 2020
Figure 42. APAC mRNA Vaccines & Therapeutics Sales Market Share by Application in 2020
Figure 43. China mRNA Vaccines & Therapeutics Revenue Growth 2016-2021 ($ Millions)
Figure 44. Japan mRNA Vaccines & Therapeutics Revenue Growth 2016-2021 ($ Millions)
Figure 45. Korea mRNA Vaccines & Therapeutics Revenue Growth 2016-2021 ($ Millions)
Figure 46. Southeast Asia mRNA Vaccines & Therapeutics Revenue Growth 2016-2021 ($ Millions)
Figure 47. India mRNA Vaccines & Therapeutics Revenue Growth 2016-2021 ($ Millions)
Figure 48. Australia mRNA Vaccines & Therapeutics Revenue Growth 2016-2021 ($ Millions)
Figure 49. Europe mRNA Vaccines & Therapeutics Sales Market Share by Country in 2020
Figure 50. Europe mRNA Vaccines & Therapeutics Revenue Market Share by Country in 2020
Figure 51. Europe mRNA Vaccines & Therapeutics Sales Market Share by Type in 2020
Figure 52. Europe mRNA Vaccines & Therapeutics Sales Market Share by Application in 2020
Figure 53. Germany mRNA Vaccines & Therapeutics Revenue Growth 2016-2021 ($ Millions)
Figure 54. France mRNA Vaccines & Therapeutics Revenue Growth 2016-2021 ($ Millions)
Figure 55. UK mRNA Vaccines & Therapeutics Revenue Growth 2016-2021 ($ Millions)
Figure 56. Italy mRNA Vaccines & Therapeutics Revenue Growth 2016-2021 ($ Millions)
Figure 57. Russia mRNA Vaccines & Therapeutics Revenue Growth 2016-2021 ($ Millions)
Figure 58. Middle East & Africa mRNA Vaccines & Therapeutics Sales Market Share by Country in 2020
Figure 59. Middle East & Africa mRNA Vaccines & Therapeutics Revenue Market Share by Country in 2020
Figure 60. Middle East & Africa mRNA Vaccines & Therapeutics Sales Market Share by Type in 2020
Figure 61. Middle East & Africa mRNA Vaccines & Therapeutics Sales Market Share by Application in 2020
Figure 62. Egypt mRNA Vaccines & Therapeutics Revenue Growth 2016-2021 ($ Millions)
Figure 63. South Africa mRNA Vaccines & Therapeutics Revenue Growth 2016-2021 ($ Millions)
Figure 64. Israel mRNA Vaccines & Therapeutics Revenue Growth 2016-2021 ($ Millions)
Figure 65. Turkey mRNA Vaccines & Therapeutics Revenue Growth 2016-2021 ($ Millions)
Figure 66. GCC Country mRNA Vaccines & Therapeutics Revenue Growth 2016-2021 ($ Millions)
Figure 67. Channels of Distribution
Figure 68. Distributors Profiles